Billerud launched SteriKraft DirectSeal on 16 November. It describes a surface-treated medical paper aimed primarily at thermo-form-fill-seal (TFFS) and pouch uses. Supplier statements about sealing, peeling and cleanliness do not certify every finished medical-device sterile-barrier system.

Shop-floor problem

Film pairing, heat-seal settings and sterilization process change seal integrity and the risk of fibre tear on opening. Nordic fresh fibre and the supplier’s contamination controls cannot be transferred automatically into a customer line’s measured cleanliness or finished-package qualification.

Illustrative concept image of a gloved hand and sealing pouch, not Billerud test or sterilization certification

Evidence to request

Obtain compatible-film range, seal temperature, pressure and dwell time, peel strength, fibre residue, bioburden-control scope and lot data. Validate the finished package separately for the actual device, sterilization method, storage and transport conditions. The launch statement contains no customer-specific finished-package test results.

Practical deliverable

Build a paper lot → film → seal settings → sterilization → integrity → peel and cleanliness → storage and transit test matrix. Document device-specific acceptance criteria and responsible approvers; compare the new and incumbent medical papers under identical conditions.

Illustrative concept image of medical pouches, not proof of finished-package barrier certification

When to hold application

Do not call a material launch finished-package sterilization certification, sterility assurance or universal film compatibility. Hold production conversion pending customer package validation and regulatory documentation.

About the Author

PackingMaster: Editor of PaperPackLog. Covers market trends, product insights, and technology in the paper packaging industry.

References

Sources checked: 2026-11-19. Supplier and institutional statements are not independent performance tests.